| 1 |
Zhou M, Wang H, Zeng X, et al. Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990—2017: A Systematic Analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2019, 394(10204): 1145-1158.
|
| 2 |
Li L, Yiin GS, Geraghty OC, et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study [J]. Lancet Neurol, 2015, 14(09): 903-913.
|
| 3 |
Hagen PT, Scholz DG, Edwards WD. Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 965 Normal Hearts [J]. Mayo ClinProc, 1984, 59(01): 17-20.
|
| 4 |
张玉顺, 朱鲜阳, 蒋世良, 等. 卵圆孔未闭处理策略中国专家建议 [J]. 心脏杂志, 2015, 27(04): 373-379.
|
| 5 |
Schnieder M, Siddiqui T, Karch A, et al. Clinical Relevance of Patent Foramen Ovale and Atrial Septum Aneurysm in Stroke: Findings of a Single-Center Cross-Sectional Study [J]. Eur Neurol, 2017, 78(NaN): 264-269.
|
| 6 |
Ryoo S, Chung J, Lee MJ, et al. An Approach to Working Up Cases of Embolic Stroke of Undetermined Source [J]. J Am Heart Assoc, 2016, 05(03): e002975.
|
| 7 |
Mojadidi MK, Zaman MO, Elgendy IY, et al. Cryptogenic Stroke and Patent Foramen Ovale [J]. J Am Coll Cardiol, 2018, 71(09): 1035-1043.
|
| 8 |
Hayashida K, Fukuchi K, Inubushi M, et al. Embolic Distribution Through Patent Foramen Ovale Demonstrated by 99mTc-MAA Brain SPECT After Valsalva Radionuclide Venography [J]. J Nucl Med, 2001, 42(06): 859-863.
|
| 9 |
Huber R, Grittner U, Weidemann F, et al. Patent Foramen Ovale and Cryptogenic Strokes inthe Stroke in Young Fabry Patients Study [J]. Stroke. 2017, 48(01): 30-35.
|
| 10 |
Ng PY, Ng AK, Subramaniam B, et al. Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke [J]. JAMA, 2018, 319(05): 452-462.
|
| 11 |
Hołda MK, Koziej M. Morphometric Features of Patent Foramen Ovale as a Risk Factor of Cerebrovascular Accidents: A Systematic Review and Meta-Analysis [J]. Cerebrovasc Dis, 2020, 49(01): 1-9.
|
| 12 |
Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke [J]. Neurology, 2013, 81(07): 619-625.
|
| 13 |
Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism [J]. Eur Heart J, 2019, 40(38): 3182-3195.
|
| 14 |
Palazzo P, Ingrand P, Agius P, et al. Transcranial Doppler to detect right-to-left shunt in cryptogenic acute ischemic stroke [J]. Brain Behav, 2018, 09(01): e01091.
|
| 15 |
Wessler BS, Kent DM, Thaler DE, et al. The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study [J]. Cerebrovasc Dis, 2015, 40(NaN): 52-58.
|
| 16 |
Anzola GP, Zavarize P, Morandi E, et al. Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale [J]. Eur J Neurol, 2003, 10(02): 129-135.
|
| 17 |
Marriott K, Manins V, Forshaw A, et al. Detection of Right-to-Left Atrial Communication Using Agitated Saline Contrast Imaging: Experience with 1162 Patients and Recommendations for Echocardiography [J]. J Am Soc Echocardiogr, 2013, 26(01): 96-102.
|
| 18 |
Li X, Gao YH, Wu SZ, et al. Contrast Transthoracic Echocardiography Using 50% Glucose as a Contrast Agent for Screening of a Patent Foramen Ovale [J]. Ultrasound Med Biol, 2018, 44(11): 2267-2273.
|
| 19 |
Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study [J]. Stroke, 1994, 25(03): 582-586.
|
| 20 |
Thiagaraj AK, Hughes-Doichev R, Biederman RWW. Provocative Maneuvers to Improve Patent Foramen Ovale Detection: A Brief Review of the Literature [J]. Echocardiography, 2019, 36(04): 783-786.
|
| 21 |
Scacciatella P, Meynet I, Giorgi M, et al. Angiography vs Transesophageal Echocardiography-Guided Patent Foramen Ovale Closure: A Propensity Score Matched Analysis of a Two-Center Registry [J]. Echocardiography, 2018, 35(06): 834-840.
|
| 22 |
Mojadidi MK, Mahmoud AN, Elgendy IY, et al. Transesophageal Echocardiography for the Detection of Patent Foramen Ovale [J]. J Am Soc Echocardiogr, 2017, 30(09): 933-934.
|
| 23 |
Kavvouras C, Vavuranakis M, Vaina S, et al. Intracardiac Echocardiography for Percutaneous Patent Foramen Ovale and Atrial Septal Defect Occlusion [J]. Herz, 2019, 44(05): 445-449.
|
| 24 |
Doherty JU, Kort S, Mehran R, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons [J]. J Am Coll Cardiol, 2019, 73(04): 488-516.
|
| 25 |
Hołda MK, Krawczyk-Ożóg A, Koziej M, et al. Cardiac computed tomography compared with two-dimensional transesophageal echocardiography for the detection and assessment of atrial septal pouches [J]. Int J Cardiovasc Imaging, 2018, 34(08): 1305-1313.
|
| 26 |
Mas JL, Derumeaux G, Guillon B, et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke [J]. N Engl J Med, 2017, 377(11): 1011-1021.
|
| 27 |
Kasner SE, Swaminathan B, Lavados P, et al. Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis from the NAVIGATE ESUS Trial [J]. Lancet Neurol, 2018, 17(12): 1053-1060.
|
| 28 |
Meier B, Kalesan B, Mattle HP, et al. Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism [J]. N Engl J Med, 2013, 368(12): 1083-1091.
|
| 29 |
Furlan AJ, Reisman M, Massaro J, et al. Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale [J]. N Engl J Med, 2012, 366(11): 991-999.
|
| 30 |
Saver JL, Carroll JD, Thaler DE, et al. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke [J]. N Engl J Med, 2017, 377(11): 1022-1032.
|
| 31 |
Søndergaard L, Kasner SE, Rhodes JF, et al. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke [J]. N Engl J Med, 2017, 377(11): 1033-1042.
|
| 32 |
Lee PH, Song JK, Kim JS, et al. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial [J]. J Am Coll Cardiol, 2018, 71(20): 2335-2342.
|
| 33 |
Kent DM, Dahabreh IJ, Ruthazer R, et al. Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis [J]. Eur Heart J, 2015, 36(35): 2381-2389.
|
| 34 |
Volpi JJ, Ridge JR, Nakum M, et al. Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective [J]. J Med Econ, 2019, 22(09): 883-890.
|
| 35 |
Stortecky S, da Costa BR, Mattle HP, et al. Percutaneous Closure of Patent Foramen Ovale in Patients with Cryptogenic Embolism: A Network Meta-Analysis [J]. Eur Heart J, 2015, 36(02): 120-128.
|
| 36 |
中华医学会心血管内科分会, 中国医师协会心血管内科分会. 卵圆孔未闭预防性封堵术中国专家共识 [J]. 中国循环杂志, 2017, 32(03): 209-214.
|